Prothena Corp Plc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.09

+0.36 (+4.12%)

As of Mar 25, 2:51 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target +48.7% upside

Low Target $9.22

Average Target $13.52

High Target $14.31

Current Price $9.09

Current
$9.09

Target
$13.52

$9.22 $13.52 avg $14.31

Scenario Analysis

Bear Case

$9.22

1.4%

Low target

Base Case

$13.52

+48.7%

Avg target

Bull Case

$14.31

+57.4%

High target

Risk/Reward

40.2x

Highly favorable

Price in Context

52-Week High

$16.67

-45.5% from high

52-Week Low

$4.32

+110.4% from low

Target vs 52W High

$13.52

-18.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%